Skip to main content
. 2021 Nov 24;53(1):2248–2257. doi: 10.1080/07853890.2021.2005254

Figure 4.

Figure 4.

Effects of UTMD-mediated miR-492 inhibitor transfection on NSCLC cell proliferation, migration and invasion. (A) UTMD-mediated miR-492 inhibitor further inhibited cell proliferation compared with transfection of miR-492 inhibitor alone. (B, C) UTMD-mediated miR-492 inhibitor further inhibited cell migration and invasion compared with a single miR-492 inhibitor (*p < .05; **p < .01; ***p < .001; #p < .05; *compare with control, #compare with miR-492 inhibitor).